News

Jade Biosciences Engages Investors at Key Upcoming Conferences

Jade Biosciences Engages Investors at Key Upcoming Conferences

Jade Biosciences to Attend Major Investor Conferences

Jade Biosciences, Inc. (Nasdaq: JBIO), a pioneering biotechnology company, is excited to announce its participation in two significant investor conferences. The company specializes in developing groundbreaking therapies aimed at treating autoimmune diseases, reflecting its commitment to addressing pressing healthcare needs.

Insights from the Leadership Team

At the upcoming H.C. Wainwright 4th Annual Kidney Virtual Conference, set for July 14, Jade's Chief Executive Officer Tom Frohlich and Chief Scientific Officer Andrew King, BVMS, Ph.D., will engage in a fireside chat at 3:00 p.m. ET. This session promises valuable insights into the company’s strategic vision and updates on ongoing developments.

Live Webcast for Investors

Investors and interested parties can catch the discussion live via a webcast available on the Investors & Media section of Jade's official website. For those who can't tune in live, an archived version will be accessible for 90 days post-event, ensuring that everyone can stay informed.

Networking Opportunities at Stifel Biotech Summit

Moreover, Jade's leadership will also partake in another key event, the 2025 Stifel Biotech Summer Summit, scheduled for August 13, where they will hold a fireside chat at 7:30 a.m. ET. These events present valuable networking opportunities for the management team, who will also host one-on-one meetings with potential and existing investors.

Showcasing Pipeline Developments

Jade Biosciences is dedicated to developing cutting-edge therapies that effectively address critical unmet needs in autoimmune diseases. One of the company’s leading candidates, JADE101, is designed to target the cytokine APRIL for the treatment of immunoglobulin A nephropathy. Successful initiation of a first-in-human clinical trial for JADE101 is anticipated in the latter half of this year, underscoring the fast pace of Jade’s developmental efforts.

In addition to JADE101, the company boasts a promising pipeline including a second candidate, JADE201, and an undisclosed antibody discovery program named JADE-003, both of which are currently advancing through preclinical development stages.

Company Background and Mission

Founded on the innovative foundation of assets licensed from Paragon Therapeutics, an established antibody discovery engine, Jade Biosciences aims to revolutionize autoimmunity treatments. With a clear mission to bring best-in-class therapies to market, the company is well-positioned to make a substantial impact in this critical healthcare sector.

Stay Connected with Jade Biosciences

For ongoing updates and more information regarding Jade Biosciences and its cutting-edge research, interested individuals can visit JadeBiosciences.com. Additionally, following the company on LinkedIn will provide insights into their journey and achievements in the biotech industry.

Frequently Asked Questions

What is Jade Biosciences known for?

Jade Biosciences is focused on creating innovative therapies for autoimmune diseases, particularly through its candidate drugs like JADE101.

When is the next investor conference Jade will attend?

The next investor conference is the H.C. Wainwright 4th Annual Kidney Virtual Conference on July 14.

How can investors watch the live presentations?

Investors can view live presentations through a webcast available on Jade's official Investors & Media web page.

What are Jade’s upcoming clinical trial plans?

Jade plans to initiate its first-in-human clinical trial for JADE101 in the second half of 2025.

Who to contact for more information about Jade Biosciences?

For inquiries, contact Priyanka Shah at Media@JadeBiosciences.com or IR@JadeBiosciences.com.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

ecozy's Brezzano Switch: Brewing Simplicity at Home

Updated Category News Views 401

Breathe the aroma, sip the innovation. ecozy just threw their Brezzano Switch into the arena, and here's the deal: it's a no-nonsense, get-your-caffeine-fix kind of machine aimed at making your mornings simple without compromising on flavor. Unique Features of the Brezzano Switch So, what's cooking? Get this—it's not just any coffee contraption. Built sleek and compact,...

Continue Reading
Johnson & Johnson Unveils Promising PsA Treatment Data

Updated Category News Views 235

A Game-Changer in Psoriatic Arthritis Treatment? Johnson & Johnson just tossed a headline-grabbing bone into the world of psoriatic arthritis with their new ICOTYDE results. For anyone tangled in the chronic web of psoriatic arthritis, hearing about a potential new treatment like ICOTYDE comes with cautious hope. Between stiff joints and rashy skin, sufferers are often...

Continue Reading
FuelCell Faces Class Action Crunch as Deadline Looms

Updated Category News Views 169

FuelCell's Legal Storm: What to Know Now You ever get that feeling when your gut knows it all before you even finish reading the headline? Well, buckle up, because FuelCell Energy, Inc. (NASDAQ:FCEL) is staring down a potential class-action train wreck, and they ain't got much track left to skid on before the deadline hits hard on November 10th, 2026. The Crunchy Details...

Continue Reading
NatGold Pulling NATG From MEXC Amid Security Concerns

Updated Category News Views 392

NatGold Digital's sudden decision to yank its NATG token off MEXC Global reeks of regulatory urgency. With the U.S. Treasury clamping down on fund transfers wrapping up MEXC in their action against Russian laundering, NatGold didn't wait for the ink to dry on that order. They’re off the exchange posthaste. A bit of foresight or sheer necessity? Well, it's got the market...

Continue Reading
Evaluating GLP-1 Telehealth? Key Questions to Consider

Updated Category News Views 390

Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...

Continue Reading
JOYEE N01 Kicks Off Global Launch with African Orders

Updated Category News Views 296

A New Chapter for JOYEE N01 There's a moment in every company's life when it either steps boldly into the future or stumbles back into obscurity. For FAW Bestune, October 28, 2026, was one of those defining moments. On this day, they launched global mass production of the JOYEE N01 in Yancheng, China. And boy, did they pull out all the stops—you don't see this kind of...

Continue Reading
Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 322

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
Aurora Innovation Faces Legal Heat Amid Delays

Updated Category News Views 219

Production Snags at Aurora Innovation Ah, investing – not for the faint-hearted. One day you're riding high, the next you're scraping by, and Aurora Innovation's (NASDAQ:AUR) investors just hit a rough patch. The autonomous trucking darling announced unexpected delays in its delivery schedule, sending shockwaves through its stock price and shaking investor confidence....

Continue Reading
Off-Broadway Play 'DUST' Raises Autism Support Funds

Updated Category News Views 337

Here's the scoop: an Off-Broadway production just did something many big hitters can't pull off. 'DUST,' a show crafted like a love letter to the American West, managed to rustle up $30,000 for young adults grappled with autism. Partnering with no less than Yale's Cultural Autism Studies and the Ed Asner Family Center, this effort hit the mark in more ways than one. An...

Continue Reading
Boston STEM Expo Sparks Young Minds in Engineering

Updated Category News Views 165

If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...

Continue Reading

Top 5 Most Recently Viewed Articles

Rick Howard Joins Knowtion Health as New CTO to Drive Innovation

Updated Category News Views 422

Rick Howard Appointed as Chief Technology Officer of Knowtion Health Knowtion Health, a prominent name in healthcare revenue cycle management, has announced its latest executive appointment. Rick Howard has joined the team as the Chief Technology Officer, bringing with him over 20 years of invaluable experience in healthcare information technology, artificial...

Continue Reading
Exploring the Untold Broadway Dream of Andy Warhol

Updated Category News Views 187

An Artistic Collaboration That Never Was A never-before-seen slice of advertising and pop culture history is coming to light. In a recent video profile, David Bartels, a veteran ad man, recounts the story of a potential Broadway collaboration with the legendary artist Andy Warhol. This ambitious project was a dazzling, provocative stage production that almost materialized...

Continue Reading
CSL Vifor and Travere Therapeutics Embrace New IgAN Guidelines

Updated Category News Views 256

Introduction to IgA Nephropathy Management The landscape of IgA Nephropathy (IgAN) treatment is evolving, and the recent updates from CSL Vifor and Travere Therapeutics mark a significant milestone. These updated clinical practice guidelines set forth by KDIGO provide a comprehensive approach to diagnosing and treating IgAN, aiming to improve outcomes for those affected...

Continue Reading
Major Insider Purchase by Christopher L Mapes at Nordson

Updated Category News Views 209

Significant Insider Purchase at Nordson In a notable move within the corporate landscape, Christopher L Mapes, who serves as the Director at Nordson (NASDAQ: NDSN), recently made a considerable investment in the company. According to recent filings, Mapes purchased 930 shares of Nordson, amounting to an impressive total of $215,713. This proactive step signals a strong...

Continue Reading
Baijiayun Group Honored as Leader in Future Medical Technology

Updated Category News Views 143

Baijiayun Group Honored for Medical Technology Innovation Baijiayun Group Ltd, known for its exceptional contributions in AI video solutions, has proudly received the title of "2024 Future Medical Technology Leader." This award highlights the company's commitment to enhancing medical technologies and practices through innovative video solutions. Leading the Charge in AI...

Continue Reading